FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lamotrigine Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Teva Pharmaceuticals (Revised 12/21/2018)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
Lamotrigine Tablets (chewable, dispersible) 5 mg, 100 count (NDC 0093-0688-01) 06/13/2018 A business decision was made to discontinue manufacture of the drug product.
Lamotrigine Tablets (chewable, dispersible) 25 mg, 100 count (NDC 0093-0132-01 ) 06/13/2018 A business decision was made to discontinue manufacture of the drug product.
Lamotrigine Tablets, USP 100 mg, 100 count (NDC 0093-0463-01) 06/13/2018 Product is currently unavailable.
Lamotrigine Tablets, USP 150 mg, 60 count (NDC 0093-7247-06) 08/27/2018 Product is currently unavailable.
25 mg tablets (NDCs 0093-0032-05 and 0093-0039-01) 12/21/2018 This product discontinuation is a business related decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English